[1]韩付金,张 静,张鸿博.马来酸曲美布汀与固本益肠片联合治疗肠易激综合征的临床效果[J].医学信息,2023,36(23):66-68，76.[doi:10.3969/j.issn.1006-1959.2023.23.016]
　HAN Fu-jin,ZHANG Jing,ZHANG Hong-bo.Clinical Effect of Trimebutine Maleate Combined with Guben Yichang Tablets in Treatment of Irritable Bowel Syndrome[J].Journal of Medical Information,2023,36(23):66-68，76.[doi:10.3969/j.issn.1006-1959.2023.23.016]
点击复制

马来酸曲美布汀与固本益肠片联合治疗肠易激综合征的临床效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年23期
页码:
66-68，76
栏目:
论著
出版日期:
2023-12-01

文章信息/Info

Title:
Clinical Effect of Trimebutine Maleate Combined with Guben Yichang Tablets in Treatment of Irritable Bowel Syndrome
文章编号:
1006-1959（2023）23-0066-04
作者:
韩付金; 张 静; 张鸿博
（天津市宁河区中医医院消化科，天津 301500）
Author(s):
HAN Fu-jin; ZHANG Jing; ZHANG Hong-bo
(Department of Gastroenterology,Tianjin Ninghe District Hospital of Traditional Chinese Medicine,Tianjin 301500,China)
关键词:
马来酸曲美布汀; 肠易激综合征; 固本益肠片; 腹泻应答; 不良反应
Keywords:
Trimebutine maleate; Irritable bowel syndrome; Guben Yichang tablets; Diarrhea response; Adverse reactions
分类号:
R574.62
DOI:
10.3969/j.issn.1006-1959.2023.23.016
文献标志码:
A
摘要:
目的 研究马来酸曲美布汀与固本益肠片联合治疗肠易激综合征（IBS）的临床效果。方法 选取2020年1月-2021年6月天津市宁河区中医医院收治的40例IBS患者，经随机数字表法分为对照组（20例）和观察组（20例），对照组采用马来酸曲美布汀治疗，观察组在其基础上联合固本益肠片治疗，比较两组肠易激综合征症状严重程度评分（IBS-SSS量表）、中医症候积分、临床疗效、腹泻、腹痛应答率及不良反应。结果 观察组治疗后IBS-SSS评分、中医症候积分低于对照组（P＜0.05）；观察组治疗总有效率为95.00%，高于对照组的75.00%（P＜0.05）；观察组治疗后4周腹泻、腹痛应答率高于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 马来酸曲美布汀联合固本益肠片治疗IBS疗效确切，可改善患者临床症状，提高腹泻、腹痛应答，安全可行。
Abstract:
Objective To study the clinical effect of trimebutine maleate combined with Guben Yichang TAblets in treatment of irritable bowel syndrome (IBS).Methods Forty patients with IBS admitted to Tianjin Ninghe District Hospital of Traditional Chinese Medicine from January 2020 to June 2021 were selected and divided into control group (20 patients) and observation group (20 patients) by random number table method. The control group was treated with trimebutine maleate, and the observation group was treated with Guben Yichang tablets on the basis of trimebutine maleate. The severity score of irritable bowel syndrome (IBS-SSS scale), TCM symptom score, clinical efficacy, diarrhea, abdominal pain response rate and adverse reactions were compared between the two groups.Results After treatment, the IBS-SSS score and TCM symptom score of the observation group were lower than those of the control group (P<0.05). The total effective rate of treatment in the observation group was 95.00%, which was higher than 75.00% in the control group (P<0.05). The response rate of diarrhea and abdominal pain in the observation group was higher than that in the control group at 4 weeks after treatment (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion Trimebutine maleate combined with Guben Yichang tablets is effective in the treatment of IBS, which can improve the clinical symptoms of patients, improve the response of diarrhea and abdominal pain, and is safe and feasible.

参考文献/References:

[1]Gracie DJ,Williams CJ,Sood R,et al.Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease[J].Clin Gastroenterol Hepatol,2017,15(3):376-384.e5.[2]何赢,张军.马来酸曲美布汀对肠易激综合征患者症状积分及炎症因子水平的影响[J].现代消化及介入诊疗,2020,25(10):1345-1348.[3]李治东,刘斯琪,陈礼平.曲美布汀联合双歧杆菌四联活菌对腹泻型肠易激综合征患者神经递质、炎症因子与肠屏障功能的影响[J].中国新药与临床杂志,2020,39(9):540-543.[4]张慧,万坚,陆芳,等.美沙拉嗪联合马来酸曲美布汀治疗肠易激综合征患者的临床疗效观察[J].国际消化病杂志,2017,37(2):95-99.[5]张云云,蹇志平.酪酸梭菌活菌片联合马来酸曲美布汀、谷维素对IBS患者的疗效[J].中国微生态学杂志,2019,31(4):439-441.[6]张旖晴,魏玮,孙晓红,等.温肾健脾法联合马来酸曲美布汀胶囊治疗腹泻型肠易激综合征脾肾阳虚证的临床疗效及对肠道菌群影响[J].长春中医药大学学报,2020,36(2):289-292.[7]Drossman DA.Functional Gastrointestinal Disorders:History, Pathophysiology, Clinical Features, and Rome IV[J].Gastroenterology,2016,150(6):1262-1279.[8]刘亚文,杨贵,杨晓华.马来酸曲美布汀联合西兰司琼治疗腹泻型肠易激综合征的疗效[J].国际消化病杂志,2019,39(1):36-39.[9]中华中医药学会脾胃病分会.肠易激综合征中医诊疗专家共识意见(2017)[J].中医杂志,2017,58(18):1614-1620.[10]Liu DR,Xu XJ,Yao SK.Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome[J].World J Gastroenterol,2018,24(1):46-57.[11]Xu XJ,Zhang YL,Liu L,et al.Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study[J].Alimentary Pharmacology & Therapeutics,2017,45(1):100-114.[12]杨雪,康长明,李汉华,等.马来酸曲美布汀治疗缓解期溃疡性结肠炎肠易激综合征样症状的疗效观察[J].实用医院临床杂志,2018,15(1):23-26.[13]植家喜,施寒艳,徐晓蓉,等.马来酸曲美布汀治疗肠易激综合征疗效及其对相关炎性介质的影响[J].疑难病杂志,2017,16(4):364-367.[14]贾晨,戚凤君,张涛,等.马来酸曲美布汀联合歧杆菌三联活菌肠溶对肠易激综合征患者的疗效分析[J].重庆医学,2017,46(29):4159-4161.[15]杨永利,宋春秋,李红霞,等.曲美布汀联合阿普唑仑对腹泻型IBS患者血清炎性因子及胃肠激素的临床研究[J].河北医学,2017,23(11):1799-1802.[16]秦芳芳,郑长清,张喆.美沙拉嗪联合固本益肠片对溃疡性结肠炎患者炎症因子及肠黏膜屏障功能的影响[J].临床消化病杂志,2020,32(3):168-171.[17]黄礼,韦祎,刘英莲.加味异功散辅助马来酸曲美布汀治疗腹泻型肠易激综合征疗效及对结肠组织酪酪肽和密封蛋白1表达的影响[J].广州中医药大学学报,2022,39(3):508-515.[18]Chen M,Qin D,Huang S,et al.Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta-analysis[J].Neurogastroenterology&Motility,2021,33(8):e14107.[19]彭志婷,李晨,胡书群.白芍总苷联合甘草酸对腹泻型肠易激综合征脑-肠组织炎性反应的作用研究[J].中国医院药学杂志,2021,41(15):1536-1540.[20]李锦伟,丁志钦,金立,等.固本益肠片联合复方谷氨酰胺和曲美布汀治疗肠易激综合征的临床研究[J].现代药物与临床,2017,32(1):63-66.[21]Tang SQ,Wang YL,Xie ZY,et al.Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome[J].Journal of Integrative Medicine,2021,19(3):274-281.[22]王菁,毕宁,方亮.参倍固肠胶囊联合马来酸曲美布汀治疗腹泻型肠易激综合征的临床研究[J].现代中西医结合杂志,2020,29(7):770-774.[23]吕歆.固本益肠片联合柳氮磺胺吡啶治疗轻中度溃疡性结肠炎的疗效观察[J].现代药物与临床,2018,33(3):560-563.

相似文献/References:

[1]陈仙梅,于晓兵,董 琳,等.肠易激综合征与功能性消化不良患者症状重叠分析[J].医学信息,2018,31(17):75.[doi:10.3969/j.issn.1006-1959.2018.17.022]
　CHEN Xian-mei,YU Xiao-bing,DONG Lin,et al.Overlapping Analysis of Symptoms in Patients with Irritable Bowel Syndrome and Functional Dyspepsia[J].Journal of Medical Information,2018,31(23):75.[doi:10.3969/j.issn.1006-1959.2018.17.022]
[2]俞 帆,李旻倩,沈 芸,等.粪菌移植治疗肠易激综合征的研究[J].医学信息,2021,34(02):50.[doi:10.3969/j.issn.1006-1959.2021.02.014]
　YU Fan,LI Min-qian,SHEN Yun,et al.Study of Fecal Bacteria Transplantation for Irritable Bowel Syndrome[J].Journal of Medical Information,2021,34(23):50.[doi:10.3969/j.issn.1006-1959.2021.02.014]
[3]黄振鹏.重视饮食管理在功能性胃肠病治疗中的作用和地位[J].医学信息,2021,34(14):1.[doi:10.3969/j.issn.1006-1959.2021.14.001]
　HUANG Zhen-peng.Emphasis on the Role and Status of Diet Management in the Treatment of Functional Gastrointestinal Disorder[J].Journal of Medical Information,2021,34(23):1.[doi:10.3969/j.issn.1006-1959.2021.14.001]
[4]伊丽娜,杨 勤.影响菌群移植效果的因素研究[J].医学信息,2022,35(03):53.[doi:10.3969/j.issn.1006-1959.2022.03.013]
　YI Li-na,YANG Qin.Factors Affecting the Efficacy of Fecal Microbiota Transplantation[J].Journal of Medical Information,2022,35(23):53.[doi:10.3969/j.issn.1006-1959.2022.03.013]
[5]方 宁,李仁君.抑郁症患者FD、IBS以及FD合并IBS患病情况分析[J].医学信息,2022,35(03):124.[doi:10.3969/j.issn.1006-1959.2022.03.031]
　FANG Ning,LI Ren-jun.Analysis of FD, IBS and FD with IBS in Depression Patients[J].Journal of Medical Information,2022,35(23):124.[doi:10.3969/j.issn.1006-1959.2022.03.031]

更新日期/Last Update: 1900-01-01